Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy

Published:2019-02-15 Issue:2 Volume:91 Page:109-117
ISSN:2309-5342
Container-title:Terapevticheskii arkhiv
language:
Short-container-title:Terapevticheskii arkhiv

Author:

Maevskaya M V,Ivashkin V T,Ivashkin K V,Lunkov V D,Liusina E O,Zozula V N,Leshchenko V I

Abstract

The article presents an update of the role of non-alcoholic fatty liver disease (NAFLD) in cardiometabolic diseases and events: arterial hypertension and components of the metabolic syndrome. A review of NAFLD modern pharmacotherapy has been conducted. Particular attention is paid to the place of ursodeoxycholic acid in the complex treatment of NAFLD.

Publisher

Consilium Medicum

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice

Link

https://ter-arkhiv.ru/0040-3660/article/viewFile/32964/pdf

Reference40 articles.

1. Ивашкин В.Т., Маевская М.В., Павлов Ч.С., Тихонов И.Н., Широкова Е.Н., Буеверов А.О., Драпкина О.М., Шульпекова Ю.О., Цуканов В.В., Маммаев С.Н., Маев И.В., Пальгова Л.К. Клинические рекомендации по диагностике и лечению неалкогольной жировой болезни печени Российского общества по изучению печени и Российской гастроэнтерологической ассоциации. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(2):24-42.

2. Драпкина О.М., Ивашкин В.Т. Эпидемиологические особенности неалкогольной жировой болезни печени в России (результаты открытого многоцентрового проспективного исследования - наблюдения DIREGL 01903). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2014;24(4):32-8.

3. Комова А.Г., Маевская М.В., Ивашкин В.Т. Принципы эффективной диагностики диффузных заболеваний печени на амбулаторном этапе. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2014;24(5):36-41.

4. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

5. Статистика смертности в России за 2016 год (Ссылка активна на 30.09.2018) [Statistica smjertnosti v Rossii za 2016. https://ritual.ru/poleznaya-informacia/articles/statistika-smertnosti-v-rossii/

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-alcoholic fatty liver disease and ultrasound markers of obesity as unfavorable factors in the course of coronary artery disease;Russian Journal of Cardiology;2024-04-09

2. Evaluation of enterohepatic circulation of the bile acids in patients with non-alcoholic fatty liver disease;Experimental and Clinical Gastroenterology;2023-10-09

3. Dynamic changes in the liver fibrosis marker FIB-4 as a predictor of adverse cardiovascular events in patients with high and very high cardiovascular risk;Experimental and Clinical Gastroenterology;2023-01-18

4. Multivariate prognosis of non-alcoholic fatty liver disease development in visceral obesity in patients with coronary artery disease and hypertension;Russian Journal of Cardiology;2021-02-17

5. Features of the therapy of non-alcoholic fatty liver disease in comorbid patients;Meditsinskiy sovet = Medical Council;2021-01-17